The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Presence of genetic aberrations in patients with brain metastases from non-small cell lung cancer (NSCLC) and clinical outcomes.
 
Robert H. Press
No Relationships to Disclose
 
Xinyan Zhang
No Relationships to Disclose
 
Richard John Cassidy
No Relationships to Disclose
 
Matthew Jeffrey Ferris
No Relationships to Disclose
 
Jim Zhong
No Relationships to Disclose
 
Conor Ernst Steuer
No Relationships to Disclose
 
Rathi Narayana Pillai
Consulting or Advisory Role - Natera
Travel, Accommodations, Expenses - Clovis Oncology; Genentech/Roche; Novartis; Takeda
 
Taofeek Kunle Owonikoko
Consulting or Advisory Role - Abbvie; Celgene; Eisai; Eisai; G1 Therapeutics; Genentech/Roche; Lilly; Novartis; Sandoz; Takeda
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); G1 Therapeutics (Inst); Novartis (Inst); Regeneron (Inst); Stem CentRx (Inst)
Patents, Royalties, Other Intellectual Property - OVERCOMING ACQUIRED RESISTANCE TO CHEMOTHERAPY TREATMENTS THROUGH SUPPRESSION OF STAT3 (Inst); SELECTIVE CHEMOTHERAPY TREATMENTS AND DIAGNOSTIC METHODS RELATED THERETO (Inst)
 
Suresh S. Ramalingam
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly/ImClone; Merck; Novartis
Travel, Accommodations, Expenses - AstraZeneca; EMD Serono; Pfizer
 
Pretesh R Patel
No Relationships to Disclose
 
Walter John Curran
Stock and Other Ownership Interests - Nanthealth
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb
Consulting or Advisory Role - eviti
Research Funding - Abbvie (Inst)
 
Hui-Kuo George Shu
No Relationships to Disclose
 
Gabriel Sica
No Relationships to Disclose
 
Kristin Ann Higgins
No Relationships to Disclose